4.7 Article

Central synaptopathy is the most conserved feature of motor circuit pathology across spinal muscular atrophy mouse models

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR)

Maya Maor-Nof et al.

Summary: The repeat expansion in the C9orf72 gene leads to activation of a specific transcriptional program, causing neurodegeneration. Removing p53 in experiments successfully rescued neuronal degeneration and extended survival.
Article Neurosciences

Chronic Pharmacological Increase of Neuronal Activity Improves Sensory-Motor Dysfunction in Spinal Muscular Atrophy Mice

Christian M. Simon et al.

Summary: The study reveals that chronic treatment with 4-aminopyridine (4-AP) improves motor behavior in both sexes of a severe mouse model of spinal muscular atrophy (SMA) by increasing neuronal activity, restoring neurotransmission and synapse numbers, particularly proprioceptive synapses and neuromuscular junctions (NMJs), without affecting motor neuron death. Additionally, combining 4-AP treatment with pharmacological inhibition of p53-dependent motor neuron death leads to additive effects, fully correcting sensory-motor circuit pathology and enhancing phenotypic benefits in SMA mice.

JOURNAL OF NEUROSCIENCE (2021)

Review Neurosciences

Spinal Muscular Atrophy: In the Challenge Lies a Solution

Brunhilde Wirth

Summary: The review highlights the challenging journey from gene discovery to therapy in spinal muscular atrophy (SMA), emphasizing the importance of perseverance in uncovering the biological mechanisms of the disease. Despite the impressive improvements seen with three therapeutic strategies in SMA, there are still many unanswered questions that need to be addressed as discussed in the review.

TRENDS IN NEUROSCIENCES (2021)

Article Neurosciences

Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn2B/- mouse model of spinal muscular atrophy

Emily J. Reedich et al.

Summary: Spinal muscular atrophy (SMA) is a neuromuscular disease caused by genetic deficiency of the SMN protein. Studies have shown activation of the p53 and p21 pathways in SMA mice, but they are not primary drivers of motor neuron death in milder SMA mouse models like Smn(2B/-).

EXPERIMENTAL NEUROLOGY (2021)

Article Cell Biology

Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA

Lingling Kong et al.

Summary: Gene replacement and pre-mRNA splicing modifier therapies show promise as breakthrough treatments for SMA, but the mechanisms underlying their variable efficacy are not fully understood. Studies in severe infantile onset human SMA tissues and mouse models reveal the importance of early treatment in improving motor neuron development and function. Genetic restoration of survival motor neuron protein in mouse motor neurons can enhance SMA motor axon development and maintenance. Early intervention is crucial to prevent neonatal axon degeneration and optimize therapeutic outcomes for SMA patients.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Medicine, Research & Experimental

Minor snRNA gene delivery improves the loss of proprioceptive synapses on SMA motor neurons

Erkan Y. Osman et al.

JCI INSIGHT (2020)

Review Neurosciences

Molecular Mechanisms Underlying Sensory-Motor Circuit Dysfunction in SMA

Hannah K. Shorrock et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)

Review Clinical Neurology

Advances in therapy for spinal muscular atrophy: promises and challenges

Ewout J. N. Groen et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Multidisciplinary Sciences

TDP-43 induces p53-mediated cell death of cortical progenitors and immature neurons

Miriam A. Vogt et al.

SCIENTIFIC REPORTS (2018)

Review Neurosciences

The Mechanisms and Functions of Synaptic Facilitation

Skyler L. Jackman et al.

NEURON (2017)

Article Multidisciplinary Sciences

SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage

Mohini Jangi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Genetics & Heredity

The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype

Seyyedmohsen Hosseinibarkooie et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2016)

Review Neurosciences

A role for the survival of motor neuron protein in mRNP assembly and transport

Paul G. Donlin-Asp et al.

CURRENT OPINION IN NEUROBIOLOGY (2016)

Article Neurosciences

Disease Mechanisms and Therapeutic Approaches in Spinal Muscular Atrophy

Sarah Tisdale et al.

JOURNAL OF NEUROSCIENCE (2015)

Article Clinical Neurology

Mechanisms Involved in Spinal Cord Central Synapse Loss in a Mouse Model of Spinal Muscular Atrophy

Olga Tarabal et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)

Review Cell Biology

SMN control of RNP assembly: From post-transcriptional gene regulation to motor neuron disease

Darrick K. Li et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)

Article Biochemistry & Molecular Biology

Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585

Julia Schreml et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2013)

Article Biochemistry & Molecular Biology

Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality

Bastian Ackermann et al.

HUMAN MOLECULAR GENETICS (2013)

Article Multidisciplinary Sciences

Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy

Zhenxi Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Biochemistry & Molecular Biology

Spinal muscular atrophy: going beyond the motor neuron

Gillian Hamilton et al.

TRENDS IN MOLECULAR MEDICINE (2013)

Article Biochemistry & Molecular Biology

An SMN-Dependent U12 Splicing Event Essential for Motor Circuit Function

Francesco Lotti et al.

Article Biochemistry & Molecular Biology

SMN Is Required for Sensory-Motor Circuit Function in Drosophila

Wendy L. Imlach et al.

Article Biochemistry & Molecular Biology

Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy

Karen K. Y. Ling et al.

HUMAN MOLECULAR GENETICS (2012)

Article Biochemistry & Molecular Biology

A Role for SMN Exon 7 Splicing in the Selective Vulnerability of Motor Neurons in Spinal Muscular Atrophy

Matteo Ruggiu et al.

MOLECULAR AND CELLULAR BIOLOGY (2012)

Article Biochemistry & Molecular Biology

The Dying-Back Phenomenon of Motor Neurons in ALS

Michal Dadon-Nachum et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2011)

Article Biochemistry & Molecular Biology

Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy

Matthew E. R. Butchbach et al.

HUMAN MOLECULAR GENETICS (2010)

Article Biochemistry & Molecular Biology

Ciliary neurotrophic factor-induced sprouting preserves motor function in a mouse model of mild spinal muscular atrophy

Christian M. Simon et al.

HUMAN MOLECULAR GENETICS (2010)

Article Biochemistry & Molecular Biology

SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy

Markus Riessland et al.

HUMAN MOLECULAR GENETICS (2010)

Article Biochemistry & Molecular Biology

Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy

Ferrill F. Rose et al.

HUMAN MOLECULAR GENETICS (2009)

Article Biochemistry & Molecular Biology

Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model

Virginia B. Mattis et al.

HUMAN MOLECULAR GENETICS (2009)

Review Neurosciences

Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Arthur H. M. Burghes et al.

NATURE REVIEWS NEUROSCIENCE (2009)

Article Clinical Neurology

Ramblings in the history of spinal muscular atrophy

Victor Dubowitz

NEUROMUSCULAR DISORDERS (2009)

Article Genetics & Heredity

Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice

Li-Kai Tsai et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2008)

Article Biochemistry & Molecular Biology

Pifithrin-α inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation

PJM Murphy et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Clinical Neurology

Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig-Hoffmann disease

G Simic et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)

Article Genetics & Heredity

A mouse model for spinal muscular atrophy

HM Hsieh-Li et al.

NATURE GENETICS (2000)